Inhibitor Therapeutics Inc
For the period ended Dec 31, 2023. Filed Mar 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 29, 2024
INTIStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Description of Property
We currently lease office space under a short-term lease in Tampa, Florida from which our finance and operations staff work.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.